Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic
COVIDCIR
Postoperative Complications and Mortality of Patients Submited to Emergency Digestive Surgery During the COVID-19 Pandemic (COVIDCIR Study): a Multicenter Cohorts' Study Protocol
1 other identifier
observational
5,307
1 country
1
Brief Summary
A multi-centre, observational cohort study will be carried out in consecutive patients operated on for urgent digestive pathology. Two cohorts will be defined: the 'pandemic' cohort, which will include all patients \[COVID-19-positive or negative\] operated on for emergency digestive pathology during the months of March to June 2020; and the control cohort, which will include all patients operated on for emergency digestive pathology during the months of March to June 2019. Information will be gathered on demographic characteristics, clinical and analytical parameters, scores on the usual risk scales for quality management in a General Surgery service (POSSUM, P-POSSUM and LUCENTUM scores), prognostic factors applicable to all patients, specific factors for patients infected with SARS-CoV-2, complications and postoperative mortality (at 30 and 90 postoperative days). In the pandemic cohort it will be detailed whether or not the patient was infected with SARS-CoV-2. The main objective will be to determine the incidence of postoperative complications and mortality. This variable will be analysed in the "full analysis set" population. Secondary objective will be to develop a specific postoperative risk propensity model for SARS-CoV-2 infected patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedFirst Submitted
Initial submission to the registry
July 19, 2020
CompletedFirst Posted
Study publicly available on registry
July 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedFebruary 23, 2021
February 1, 2021
6 months
July 19, 2020
February 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day mortality
Mortality for any cause at 30 days after urgent gastrointestinal surgery.
30 days post-surgery
Secondary Outcomes (4)
90-day mortality
90 days post-surgery
Postoperative complications
30 days post-surgery
Severe complications
30 days post-surgery
Lenght of stay
90 days post-surgery
Study Arms (3)
Pandemic Covid-positive cohort
All Covid-positive patients operated on for emergency digestive pathology from March, 1st 2020 to June, 30th 2020
Pandemic Covid-negative cohort
All Covid-negative patients operated on for emergency digestive pathology from March, 1st 2020 to June, 30th 2020
Control cohort
Pre-pandemic cohort: all patients operated on for emergency digestive pathology from March, 1st 2020 to June, 30th 2019.
Eligibility Criteria
Patients operated on for emergency/urgent gastrointestinal surgery constitute the target population.
You may qualify if:
- Patients ≥18 years, both genders, and operated on for urgent/emergency gastrointestinal pathology.
You may not qualify if:
- Patients who have undergone a scheduled surgical intervention or patients operated on by a service other than General and Digestive Surgery.
- Patients \< 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Related Publications (2)
Osorio J, Madrazo Z, Videla S, Sainz B, Rodriguez-Gonzalez A, Campos A, Santamaria M, Pelegrina A, Gonzalez-Serrano C, Aldeano A, Sarriugarte A, Gomez-Diaz CJ, Ruiz-Luna D, Garcia-Ruiz-de-Gordejuela A, Gomez-Gavara C, Gil-Barrionuevo M, Vila M, Clavell A, Campillo B, Millan L, Olona C, Sanchez-Cordero S, Medrano R, Lopez-Arevalo CA, Perez-Romero N, Artigau E, Calle M, Echenagusia V, Otero A, Tebe C, Pallares N, Biondo S; COVID-CIR Collaborative Group Members of the COVID-CIR Collaborative Group. Analysis of outcomes of emergency general and gastrointestinal surgery during the COVID-19 pandemic. Br J Surg. 2021 Dec 1;108(12):1438-1447. doi: 10.1093/bjs/znab299.
PMID: 34535796DERIVEDMadrazo Z, Osorio J, Otero A, Biondo S, Videla S; on behalf of The COVID-CIR Collaborative Group. Postoperative complications and mortality following emergency digestive surgery during the COVID-19 pandemic: A multicenter collaborative retrospective cohort study protocol (COVID-CIR). Medicine (Baltimore). 2021 Feb 5;100(5):e24409. doi: 10.1097/MD.0000000000024409.
PMID: 33592888DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Javier Osorio, MD, PhD
Hospital Universitary de Bellvitge
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Javier Osorio
Study Record Dates
First Submitted
July 19, 2020
First Posted
July 21, 2020
Study Start
March 1, 2020
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
February 23, 2021
Record last verified: 2021-02